45P MITO39: Effiacy and tolerability of PLD-trabectedin in the treatment of relapsed ovarian cancer after maintenance therapy with PARP-i, a MITO observational case-control study
Title:
45P MITO39: Effiacy and tolerability of PLD-trabectedin in the treatment of relapsed ovarian cancer after maintenance therapy with PARP-i, a MITO observational case-control study
Author:
Turinetto, M. Pignata, S. Pisano, C. Zamagni, C. Cassani, C. Malaguti, P. Parisi, A. Scollo, P. Scandurra, G. Palaia, I. Ricotti, A. Bergamini, A. Tuninetti, V. Scotto, G. Valabrega, G.